Compare CVS Health Corp (CVS) vs Icl Group Ltd (ICL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Icl Group Ltd — how do they compare? CVS Health Corp trades at $86.82 (market cap $112.49B), while Icl Group Ltd trades at $5.01 (market cap $6.60B). The key difference: CVS Health Corp is far larger — about 17× Icl Group Ltd's market cap, and Icl Group Ltd pays the higher dividend (4.05%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Icl Group Ltd for 56 Days on average.
| CVS | ICL | |
|---|---|---|
Market Cap | $112.49B | $6.60B |
Volume | 8,467,392 | 824,784 |
Sector | Health | Basic Materials |
52-Week High | $110.60 | $6.84 |
52-Week Low | $70.08 | $4.80 |
Typical Hold Time | 83 Days | 56 Days |
Enterprise Value | $174.83B | $9.24B |
Dividend Yield | 3.02% | 4.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
ICL Group trades at $5.00, down 1.57% today, with a bearish technical outlook despite recent earnings beats. The company shows stable revenue around $7.2B but declining net margins from 21.55% in 2022 to 3.15% in 2025. Analyst consensus is neutral with 100% hold ratings and a $6.08 price target, suggesting 22% upside. Recent news highlights dividend strength and Q2 2026 earnings beat.
ICL offers value with low P/S (0.85) and EV/EBITDA (6.77) ratios, but faces profitability pressures from industry headwinds. The primary risk is margin compression from higher input costs, while institutional buying and dividend yield provide support. The stock presents a cautious opportunity for value investors willing to withstand sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Icl Group Ltd
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.
Read more on ICL →
